Pneomococcal Vaccine Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Safety and Immunogenicity of V116 in Vaccine-na ïve Japanese Older Adults (V116-009, STRIDE-9)
Condition: Pneumococcal Disease Interventions: Biological: V116; Biological: PPSV23 Sponsor: Merck Sharp & Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2022 Category: Research Source Type: clinical trials
